Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Allogeneic PBSC Transplant for CML
NCT00001144Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Oct 1999
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic peripheral blood progenitor cells in chronic myeloid leukemia (CML), sponsored by National Heart, Lung, and Blood Institute. Started Oct 1999; status: completed.
02
Drugs
allogeneic peripheral blood progenitor cells
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00001144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001144.